Imricor Medical Systems (ASX: IMR) is activating a new iCMR site in Zagreb, Croatia.
The company said the Clinical Hospital Dubrava has placed an order for its capital equipment, and installation is targeted for the end of October. Procedures are expected to commence this quarter.
Under the terms of the procurement contract, Dubrava will order a minimum of 50 procedures worth of consumable product within the next 12 months.
Imricor’s chair and CEO Steve Wedan said, “The clinical market is showing signs of opening up once again, and we are thrilled to be commencing procedures at Dubrava, our first site Croatia. While this site is not a dedicated cardiology-owned iCMR lab, they have good MRI capacity and a great partnership between cardiology and radiology, so we do not expect the cases to be limited by the lab’s availability. “As I noted previously, activating sites is a key focus for our European sales team, and Dubrava is the direct result of that focus. There are a number of additional sites that we expect to activate in the coming months.”